Balstilimab Antibody
Balstilimab (AGEN2034) is a fully human IgG4 monoclonal antibody targeting the PD-1 immune checkpoint. It is utilized in research for investigating cancer immunotherapy, with studies demonstrating its activity in both in vitro assays and in vivo tumor models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
8.54 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LVP561 1 x 10^7 IFU/mL - 200 µL
niRFP (EF1a, Puro) Lentiviral particles
Sign In for Pricing
View Details 
CC553-D 5 µm
Caprisil Diol HPLC Column, 5 µm, 100 Å, CC553-D x 150 mm
Sign In for Pricing
View Details